Fourteen mutations were analyzed with ASO–qPCR in Group PT, and twelve (two for each T patient and one for each P patient) could be confirmed in the tumor biopsies (OR10A4-rs547489107 and NLRP6-NM_138329.2:c.403G > T were undetected), as reported in Table 2. The gene discussed is OR10A4; the disease is neoplasm.